Large-scale testing (Phase 3)Study completedNCT04120194What this trial is testingPhase 3 Pivotal Trial of NanoFlu™ in Older AdultsWho this might be right forInfluenza, Human Novavax 2,654
Early research (Phase 1)Study completedNCT05398796What this trial is testingDose Escalation, Open-Label Clinical Trial to Evaluate Safety, Tolerability and Immunogenicity of a Nipah Virus (NiV) mRNA Vaccine, mRNA-1215, in Healthy AdultsWho this might be right forNipah Virus Infection National Institute of Allergy and Infectious Diseases (NIAID) 40
Not applicableLooking for participantsNCT07358910What this trial is testingRisk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health PerspectiveWho this might be right forDengueChikungunyaZika Virus Infection+55 more Institut Pasteur du Cambodge 10,000
Testing effectiveness (Phase 2)Ended earlyNCT03658629What this trial is testingPhase 2 Dose and Formulation Confirmation of Quad-NIV in Older AdultsWho this might be right forInfluenza, Human Novavax 1,375
Testing effectiveness (Phase 2)UnknownNCT01811784What this trial is testingCommunity Intervention to Prevent Nipah SpilloverWho this might be right forHuman NiV Infection International Centre for Diarrhoeal Disease Research, Bangladesh 7,782